Results 151 to 160 of about 3,597,475 (336)

Two bipolar disorders or one? In reply to commentary by Malhi and Bell

International Journal of Bipolar Disorders, 2022
Leonardo Tondo, Alessandro Miola, Marco Pinna, Martina Contu, Ross J. Baldessarini   +4 more
doaj   +1 more source

CYP2C19 Genotype is Associated with Citalopram Treatment Outcomes in a Real‐World Setting

Clinical Pharmacology &Therapeutics, EarlyView.
CYP2C19 metabolizes various selective serotonin reuptake inhibitors (SSRIs) and genetic CYP2C19 variants are associated with SSRI tolerability and response. Yet, whether CYP2C19 variability also impacts citalopram response remained unclear. We here evaluated associations between CYP2C19 genotypes and citalopram prescription data of 11,079 patients from
Yoomi Park, Yitian Zhou, Volker M. Lauschke   +2 more
wiley   +1 more source

Genomic Insights Into Risperidone Treatment Outcomes in Children and Adolescents: Experience From a Psychiatric Hospital Serving Rural Youth

Clinical Pharmacology &Therapeutics, EarlyView.
Risperidone is a commonly used antipsychotic for treating psychiatric illness in children and adolescents. There is a large variability in risperidone response and discontinuation rates remain high. Pharmacogenomics offers the opportunity to improve risperidone outcomes, yet studies in pediatric populations are limited.
Jack W. Staples, Shayna R. Killam, Karen E. Brown, Rachel Dalton, Elizabeth Sather, Qiang Chen, Joshua Loveland, Corbin Schwanke, Abdallah F. Elias, Kristin L. Bigos, Erica L. Woodahl   +10 more
wiley   +1 more source

Comparison of beta-endorphin and CGRP levels before and after treatment for severe schizophrenia

Neuropsychiatric Disease and Treatment, 2016
Małgorzata Urban-Kowalczyk,1 Janusz Śmigielski,2 Dominik Strzelecki1 1Department of Affective and Psychotic Disorders, 2Department of Geriatrics, Healthy Aging Research Centre (HARC), Medical University of Lodz, Lodz, Poland ...
Urban-Kowalczyk M, Smigielski J, Strzelecki D   +2 more
doaj  

Cannabidiol in Anorexia Nervosa: A Double‐Blind Randomized Placebo Controlled Pilot Study to Test Safety, Pharmacokinetics, and Symptom Change

International Journal of Eating Disorders, EarlyView.
ABSTRACT Objective Anorexia nervosa (AN) is a severe psychiatric disorder marked by an intense fear of gaining weight and persistent body dissatisfaction, both during periods of underweight and after weight restoration. The endocannabinoid system may offer therapeutic benefits, particularly in reducing anxiety.
Neha Sahota, David J. Grelotti, Tyler Nguyen, Walter H. Kaye, Skylar Swindle, Raymond Suhandynata, Spencer Seely, Megan E. Shott, Guido K. W. Frank   +8 more
wiley   +1 more source

The Impact of Emotion Coaching on Changes in Caregiver Burden and Distress Tolerance During Family‐Based Treatment

International Journal of Eating Disorders, EarlyView.
ABSTRACT Objective Caregivers often experience elevated stress while supporting a loved one with an eating disorder. This study was a secondary analysis exploring changes in caregiver burden (EDSIS), distress tolerance (DTS), and emotion regulation (ERQ) during family‐based treatment (FBT) among caregivers high in expressed emotion (EE) participating ...
Rachel Kramer, Kimberly Stevens, Megan E. Mikhail, Daniel Le Grange, Anne Shaffer, Claire M. Aarnio‐Peterson   +5 more
wiley   +1 more source

Latent Trajectories of Body Mass Index and Depressive Symptoms in Inpatients With Anorexia Nervosa: Predictors and Outcomes

International Journal of Eating Disorders, EarlyView.
ABSTRACT Objective Inpatient treatment aimed at weight restoration and psychiatric stabilization is often required for individuals with anorexia nervosa (AN). This study aimed to identify distinct trajectories of change in body mass index (BMI) and depressive symptoms during inpatient treatment, examine clinical predictors and outcomes, and test ...
Matteo Martini, Mie Sedoc Jørgensen, Cristiano Dani, Anne Bryde Christensen, Magnus Sjögren, Nadia Micali   +5 more
wiley   +1 more source

Co‐Producing the Transition to Eating Disorder Youth Intervention: Experience‐Based Co‐Design Workshops Supporting Young People in Transition

International Journal of Eating Disorders, EarlyView.
ABSTRACT Objective Eating disorders (EDs) are severe and complex psychiatric illnesses, with adolescence and young adulthood representing particularly vulnerable periods for onset, relapse and disruptions in treatment. The transition from Child and Adolescent Mental Health Services (CAMHS) to Adult Mental Health Services (AMHS) is especially complex ...
Maria Livanou, Marta Marlais, Charlotte Burton, Nora Kornai, Anna Bromley, Pareena Dutt, Jiarui Li, Tiffany Luxford, Francesca Marshall, Maria Georgia Dioletta, Molly Henson, Jun Teh, Emily Nuttall, Ashish Kumar, Kevin Christian, Carolyn Hatton, Zara Smalley, Grace Hill, Anya Heneghan, Kat Novogrudsky   +19 more
wiley   +1 more source

Interactions between variation in candidate genes and environmental factors in the etiology of schizophrenia and bipolar disorder : a systematic review [PDF]

, 2018
Schizophrenia and bipolar disorder (BD) are complex and multidimensional disorders with high heritability rates. The contribution of genetic factors to the etiology of these disorders is increasingly being recognized as the action of multiple risk ...
Frydecka, Dorota, Gawęda, Łukasz, Misiak, Błażej, Mustafa, Ahmed A, Prochwicz, Katarzyna, Stramecki, Filip, Sąsiadek, Maria M   +6 more
core  

A Program‐Led Motivational App (MI‐Coach: ED) for Eating Disorder Waitlists: Findings From a Feasibility and Acceptability Pilot Trial

International Journal of Eating Disorders, EarlyView.
ABSTRACT Objective Individuals with eating disorders (EDs) often face significant barriers to accessing care, including prolonged waitlists and systemic delays. Digital interventions, such as mobile apps, offer a scalable way to enhance pre‐treatment engagement during this high‐risk period.
Amané Halicki‐Asakawa, Emily Fuller, Maya Libben   +2 more
wiley   +1 more source